{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:58:26Z","timestamp":1788357506169,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","award":["190345"],"award-info":[{"award-number":["190345"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["2018\/703"],"award-info":[{"award-number":["2018\/703"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["2018\/735"],"award-info":[{"award-number":["2018\/735"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018-02614"],"award-info":[{"award-number":["2018-02614"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2015051"],"award-info":[{"award-number":["2015051"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2018061"],"award-info":[{"award-number":["2018061"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsofoncology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.annonc.2022.02.226","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T13:25:20Z","timestamp":1646745920000},"page":"649-656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Inflammatory bowel disease and risk of adenocarcinoma and neuroendocrine tumors in the small bowel"],"prefix":"10.1016","volume":"33","author":[{"given":"J.","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Refsum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.","family":"Helsingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Wieszczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"L\u00f8berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bretthauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.O.","family":"Adami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kalager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.annonc.2022.02.226_bib1","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.cgh.2017.06.051","article-title":"Inflammatory bowel disease and small bowel cancer risk, clinical characteristics, and histopathology: a population-based study","volume":"15","author":"Bojesen","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.annonc.2022.02.226_bib2","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/ajg.2013.249","article-title":"Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study","volume":"108","author":"Jess","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.annonc.2022.02.226_bib3","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1158\/1055-9965.EPI-10-1281","article-title":"Crohn\u2019s disease and small bowel adenocarcinoma: a population-based case-control study","volume":"20","author":"Shaukat","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.annonc.2022.02.226_bib4","doi-asserted-by":"crossref","first-page":"j3951","DOI":"10.1136\/bmj.j3951","article-title":"Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014","volume":"358","author":"Ol\u00e9n","year":"2017","journal-title":"BMJ"},{"issue":"33","key":"10.1016\/j.annonc.2022.02.226_bib5","doi-asserted-by":"crossref","first-page":"11486","DOI":"10.3748\/wjg.v20.i33.11486","article-title":"Small bowel adenocarcinoma and Crohn\u2019s disease: any further ahead than 50 years ago?","volume":"20","author":"Cahill","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.annonc.2022.02.226_bib6","first-page":"1823","article-title":"Incidence, presentation, and prognosis of small bowel adenocarcinoma in patients with small bowel Crohn\u2019s disease: a prospective observational study","volume":"19","author":"Elriz","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.annonc.2022.02.226_bib7","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00432-020-03496-0","article-title":"Inflammatory bowel disease and risk of gastric, small bowel and colorectal cancer: a meta-analysis of 26 observational studies","volume":"147","author":"Wan","year":"2021","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.annonc.2022.02.226_bib8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/jgh.15229","article-title":"Intestinal cancer in patients with Crohn\u2019s disease: a systematic review and meta-analysis","volume":"36","author":"Uchino","year":"2021","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.annonc.2022.02.226_bib9","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10350-006-0848-z","article-title":"The risk of cancer in patients with Crohn\u2019s disease","volume":"50","author":"von Roon","year":"2007","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"10.1016\/j.annonc.2022.02.226_bib10","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s11605-010-1402-9","article-title":"Intestinal cancer risk in Crohn\u2019s disease: a meta-analysis","volume":"15","author":"Laukoetter","year":"2011","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"12","key":"10.1016\/j.annonc.2022.02.226_bib11","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1111\/j.1572-0241.2005.00287.x","article-title":"Increased risk of intestinal cancer in Crohn\u2019s disease: a meta-analysis of population-based cohort studies","volume":"100","author":"Jess","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.annonc.2022.02.226_bib12","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1365-2036.2006.02854.x","article-title":"Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn\u2019s disease","volume":"23","author":"Canavan","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.annonc.2022.02.226_bib13","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/gutjnl-2015-311003","article-title":"The continuing uncertainty about cancer risk in inflammatory bowel disease","volume":"65","author":"Adami","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.annonc.2022.02.226_bib14","series-title":"The National Patient Register","year":"2019"},{"issue":"1","key":"10.1016\/j.annonc.2022.02.226_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1403494819859737","article-title":"The Norwegian Patient Registry and the Norwegian Registry for Primary Health Care: research potential of two nationwide health-care registries","volume":"48","author":"Bakken","year":"2020","journal-title":"Scand J Public Health"},{"issue":"2","key":"10.1016\/j.annonc.2022.02.226_bib16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/00365521.2016.1246605","article-title":"Validating inflammatory bowel disease (IBD) in the Swedish National Patient Register and the Swedish Quality Register for IBD (SWIBREG)","volume":"52","author":"Jakobsson","year":"2017","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"10.1016\/j.annonc.2022.02.226_bib17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.annonc.2022.02.226_bib18","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3109\/0284186X.2013.857429","article-title":"Systematic underreporting of the population-based incidence of pancreatic and biliary tract cancers","volume":"53","author":"Kilander","year":"2014","journal-title":"Acta Oncol"},{"issue":"3","key":"10.1016\/j.annonc.2022.02.226_bib19","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/hep.28775","article-title":"The underreporting of hepatocellular\u00a0carcinoma to the cancer register and a log-linear model to estimate a more correct incidence","volume":"65","author":"T\u00f6rner","year":"2017","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.annonc.2022.02.226_bib20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3748\/wjg.v17.i6.697","article-title":"Primary gastrointestinal lymphoma","volume":"17","author":"Ghimire","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.annonc.2022.02.226_bib21","series-title":"Statistical methods in cancer research. Volume II--The design and analysis of cohort studies","first-page":"1","author":"Breslow","year":"1987"},{"issue":"3","key":"10.1016\/j.annonc.2022.02.226_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2036.2004.01858.x","article-title":"Intestinal and extra-intestinal cancer in Crohn\u2019s disease: follow-up of a population-based cohort in Copenhagen County, Denmark","volume":"19","author":"Jess","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.annonc.2022.02.226_bib23","first-page":"297","article-title":"Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden","volume":"70","author":"Axelrad","year":"2021","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.annonc.2022.02.226_bib24","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/1097-0142(19890115)63:2<360::AID-CNCR2820630227>3.0.CO;2-9","article-title":"Small bowel carcinoma in Crohn\u2019s disease. Distinguishing features and risk factors","volume":"63","author":"Senay","year":"1989","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.annonc.2022.02.226_bib25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/ecco-jcc\/jjz157","article-title":"Small bowel adenocarcinoma: is there a difference in survival for Crohn\u2019s versus Sporadic cases?","volume":"14","author":"Fields","year":"2020","journal-title":"J\u00a0Crohns Colitis"},{"issue":"1","key":"10.1016\/j.annonc.2022.02.226_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00054725-200401000-00005","article-title":"Small intestinal adenocarcinoma in Crohn\u2019s disease: a case-control study","volume":"10","author":"Solem","year":"2004","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"10.1016\/j.annonc.2022.02.226_bib27","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/000313480707301122","article-title":"Small bowel adenocarcinoma complicating Crohn\u2019s disease: case series and review of the literature","volume":"73","author":"Dossett","year":"2007","journal-title":"Am Surg"},{"issue":"1","key":"10.1016\/j.annonc.2022.02.226_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4291\/wjgp.v7.i1.117","article-title":"Small bowel neuroendocrine tumors: from pathophysiology to clinical approach","volume":"7","author":"Xavier","year":"2016","journal-title":"World J Gastrointest Pathophysiol"},{"issue":"9","key":"10.1016\/j.annonc.2022.02.226_bib29","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/ibd.20172","article-title":"Carcinoid tumors are 15 times more common in patients with Crohn\u2019s disease","volume":"13","author":"West","year":"2007","journal-title":"Inflamm Bowel Dis"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753422003623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753422003623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T06:09:25Z","timestamp":1760335765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753422003623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0923753422003623"],"URL":"https:\/\/doi.org\/10.1016\/j.annonc.2022.02.226","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory bowel disease and risk of adenocarcinoma and neuroendocrine tumors in the small bowel","name":"articletitle","label":"Article Title"},{"value":"Annals of Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annonc.2022.02.226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}]}}